Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

4,752 questions · 6,648 findings · 688 reviews

No studies found 1,125 · 16.9%GRADE not reported 670 · 10.1%Very low 1,796 · 27%Low 1,685 · 25.3%Moderate 1,075 · 16.2%High 297 · 4.5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Balloon (Foley or ATAD) vs vaginal prostaglandin E2

Uterine hyperstimulation with fetal heart rate changes · third trimester induction of labour in women with a viable fetus

Balloon (Foley or ATAD) probably leads to lower uterine hyperstimulation with FHR changes compared with vaginal prostaglandin E2 (moderate certainty).

1 finding from 1 review

Balloon (Foley or ATAD) vs vaginal prostaglandin E2

Serious neonatal morbidity or perinatal death · third trimester induction of labour in women with a viable fetus

Balloon (Foley or ATAD) probably leads to lower serious neonatal morbidity or perinatal death compared with vaginal prostaglandin E2 (moderate certainty).

1 finding from 1 review

Balloon (Foley or ATAD) vs vaginal prostaglandin E2

Serious maternal morbidity or death · third trimester induction of labour in women with a viable fetus

It is very uncertain whether balloon (Foley or ATAD) changes serious maternal morbidity or death compared with vaginal prostaglandin E2 (very low certainty).

1 finding from 1 review

Balloon (Foley or ATAD) vs vaginal prostaglandin E2

Admission to neonatal intensive care unit · third trimester induction of labour in women with a viable fetus

Balloon (Foley or ATAD) showed no clear difference in neonatal intensive care unit admission compared with vaginal prostaglandin E2 (low certainty).

1 finding from 1 review

Balloon (Foley or ATAD) vs low‐dose vaginal misoprostol

Uterine hyperstimulation with fetal heart rate changes · third trimester induction of labour in women with a viable fetus

Balloon (Foley or ATAD) probably leads to lower uterine hyperstimulation with FHR changes compared with low‐dose vaginal misoprostol (moderate certainty).

1 finding from 1 review